Global STD Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global STD Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD 27470 million by 2025, from USD 22230 million in 2019.
The STD Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
STD Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, STD Diagnostics market has been segmented into:
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
By Application, STD Diagnostics has been segmented into:
Laboratory Testing
Point of Care Testing
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global STD Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level STD Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global STD Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the STD Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and STD Diagnostics Market Share Analysis
STD Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, STD Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the STD Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in STD Diagnostics are:
Abbott
Bio/Data
Alere/Biosite/Inverness
ADI/American Diagnostica
Becton Dickinson
Agilent Technologies
Diadexus
Beckman Coulter/Danaher
Axis-Shield
Decode Genetics
Qiagen
Sequenom
Diagnocure
Sienco
Roche
Polymedco
Diagnostica Stago/Trinity Biotech
Siemens
SDIX
Diamedix
Sysmex
Zycare/Alere
Wako
Tosoh
Takara Bio
ThermoFisher
Table of Contents
1 STD Diagnostics Market Overview
1.1 Product Overview and Scope of STD Diagnostics
1.2 Classification of STD Diagnostics by Type
1.2.1 Global STD Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global STD Diagnostics Revenue Market Share by Type in 2019
1.2.3 Chlamydia Testing
1.2.4 Syphilis Testing
1.2.5 Gonorrhea Testing
1.2.6 Herpes Simplex Virus Testing
1.2.7 Human Papilloma Virus Testing
1.2.8 Human Immunodeficiency Virus Testing
1.2.9 Chancroid Testing
1.3 Global STD Diagnostics Market by Application
1.3.1 Overview: Global STD Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Laboratory Testing
1.3.3 Point of Care Testing
1.4 Global STD Diagnostics Market by Regions
1.4.1 Global STD Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of STD Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) STD Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) STD Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) STD Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) STD Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) STD Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio/Data
2.2.1 Bio/Data Details
2.2.2 Bio/Data Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio/Data SWOT Analysis
2.2.4 Bio/Data Product and Services
2.2.5 Bio/Data STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Alere/Biosite/Inverness
2.3.1 Alere/Biosite/Inverness Details
2.3.2 Alere/Biosite/Inverness Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Alere/Biosite/Inverness SWOT Analysis
2.3.4 Alere/Biosite/Inverness Product and Services
2.3.5 Alere/Biosite/Inverness STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 ADI/American Diagnostica
2.4.1 ADI/American Diagnostica Details
2.4.2 ADI/American Diagnostica Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ADI/American Diagnostica SWOT Analysis
2.4.4 ADI/American Diagnostica Product and Services
2.4.5 ADI/American Diagnostica STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Becton Dickinson
2.5.1 Becton Dickinson Details
2.5.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Becton Dickinson SWOT Analysis
2.5.4 Becton Dickinson Product and Services
2.5.5 Becton Dickinson STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Diadexus
2.7.1 Diadexus Details
2.7.2 Diadexus Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Diadexus SWOT Analysis
2.7.4 Diadexus Product and Services
2.7.5 Diadexus STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beckman Coulter/Danaher
2.8.1 Beckman Coulter/Danaher Details
2.8.2 Beckman Coulter/Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beckman Coulter/Danaher SWOT Analysis
2.8.4 Beckman Coulter/Danaher Product and Services
2.8.5 Beckman Coulter/Danaher STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Axis-Shield
2.9.1 Axis-Shield Details
2.9.2 Axis-Shield Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Axis-Shield SWOT Analysis
2.9.4 Axis-Shield Product and Services
2.9.5 Axis-Shield STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Decode Genetics
2.10.1 Decode Genetics Details
2.10.2 Decode Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Decode Genetics SWOT Analysis
2.10.4 Decode Genetics Product and Services
2.10.5 Decode Genetics STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Qiagen SWOT Analysis
2.11.4 Qiagen Product and Services
2.11.5 Qiagen STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sequenom
2.12.1 Sequenom Details
2.12.2 Sequenom Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sequenom SWOT Analysis
2.12.4 Sequenom Product and Services
2.12.5 Sequenom STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Diagnocure
2.13.1 Diagnocure Details
2.13.2 Diagnocure Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Diagnocure SWOT Analysis
2.13.4 Diagnocure Product and Services
2.13.5 Diagnocure STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sienco
2.14.1 Sienco Details
2.14.2 Sienco Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Sienco SWOT Analysis
2.14.4 Sienco Product and Services
2.14.5 Sienco STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Roche SWOT Analysis
2.15.4 Roche Product and Services
2.15.5 Roche STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Polymedco
2.16.1 Polymedco Details
2.16.2 Polymedco Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Polymedco SWOT Analysis
2.16.4 Polymedco Product and Services
2.16.5 Polymedco STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Diagnostica Stago/Trinity Biotech
2.17.1 Diagnostica Stago/Trinity Biotech Details
2.17.2 Diagnostica Stago/Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Diagnostica Stago/Trinity Biotech SWOT Analysis
2.17.4 Diagnostica Stago/Trinity Biotech Product and Services
2.17.5 Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Siemens
2.18.1 Siemens Details
2.18.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Siemens SWOT Analysis
2.18.4 Siemens Product and Services
2.18.3 Siemens STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.19 SDIX
2.19.1 SDIX Details
2.19.2 SDIX Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 SDIX SWOT Analysis
2.19.4 SDIX Product and Services
2.19.5 SDIX STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Diamedix
2.20.1 Diamedix Details
2.20.2 Diamedix Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Diamedix SWOT Analysis
2.20.4 Diamedix Product and Services
2.20.5 Diamedix STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.21 Sysmex
2.21.1 Sysmex Details
2.21.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Sysmex SWOT Analysis
2.21.4 Sysmex Product and Services
2.21.5 Sysmex STD Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.22 Zycare/Alere
2.23 Wako
2.24 Tosoh
2.25 Takara Bio
2.26 ThermoFisher
3 Market Competition, by Players
3.1 Global STD Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 STD Diagnostics Players Market Share
3.2.2 Top 10 STD Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global STD Diagnostics Revenue and Market Share by Regions
4.2 North America STD Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe STD Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific STD Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America STD Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa STD Diagnostics Revenue and Growth Rate (2015-2020)
5 North America STD Diagnostics Revenue by Countries
5.1 North America STD Diagnostics Revenue by Countries (2015-2020)
5.2 USA STD Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada STD Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico STD Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe STD Diagnostics Revenue by Countries
6.1 Europe STD Diagnostics Revenue by Countries (2015-2020)
6.2 Germany STD Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK STD Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France STD Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia STD Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy STD Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific STD Diagnostics Revenue by Countries
7.1 Asia-Pacific STD Diagnostics Revenue by Countries (2015-2020)
7.2 China STD Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan STD Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea STD Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India STD Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia STD Diagnostics Revenue and Growth Rate (2015-2020)
8 South America STD Diagnostics Revenue by Countries
8.1 South America STD Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil STD Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina STD Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue STD Diagnostics by Countries
9.1 Middle East & Africa STD Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia STD Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE STD Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt STD Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa STD Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global STD Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global STD Diagnostics Market Forecast by Type (2019-2024)
10.3 Chlamydia Testing Revenue Growth Rate (2015-2025)
10.4 Syphilis Testing Revenue Growth Rate (2015-2025)
10.5 Gonorrhea Testing Revenue Growth Rate (2015-2025)
10.6 Herpes Simplex Virus Testing Revenue Growth Rate (2015-2025)
10.7 Human Papilloma Virus Testing Revenue Growth Rate (2015-2025)
10.8 Human Immunodeficiency Virus Testing Revenue Growth Rate (2015-2025)
10.9 Chancroid Testing Revenue Growth Rate (2015-2025)
11 Global STD Diagnostics Market Segment by Application
11.1 Global STD Diagnostics Revenue Market Share by Application (2015-2020)
11.2 STD Diagnostics Market Forecast by Application (2019-2024)
11.3 Laboratory Testing Revenue Growth (2015-2020)
11.4 Point of Care Testing Revenue Growth (2015-2020)
12 Global STD Diagnostics Market Size Forecast (2021-2025)
12.1 Global STD Diagnostics Market Size Forecast (2021-2025)
12.2 Global STD Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America STD Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe STD Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific STD Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America STD Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa STD Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global STD Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of STD Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global STD Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market STD Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott STD Diagnostics Major Business
Table 7. Abbott STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott STD Diagnostics Product and Solutions
Table 10. Abbott STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bio/Data Corporate Information, Location and Competitors
Table 12. Bio/Data STD Diagnostics Major Business
Table 13. Bio/Data STD Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Bio/Data SWOT Analysis
Table 15. Bio/Data STD Diagnostics Product and Solutions
Table 16. Bio/Data STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Alere/Biosite/Inverness Corporate Information, Location and Competitors
Table 18. Alere/Biosite/Inverness STD Diagnostics Major Business
Table 19. Alere/Biosite/Inverness STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Alere/Biosite/Inverness SWOT Analysis
Table 21. Alere/Biosite/Inverness STD Diagnostics Product and Solutions
Table 22. Alere/Biosite/Inverness STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. ADI/American Diagnostica Corporate Information, Location and Competitors
Table 24. ADI/American Diagnostica STD Diagnostics Major Business
Table 25. ADI/American Diagnostica STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. ADI/American Diagnostica SWOT Analysis
Table 27. ADI/American Diagnostica STD Diagnostics Product and Solutions
Table 28. ADI/American Diagnostica STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Becton Dickinson Corporate Information, Location and Competitors
Table 30. Becton Dickinson STD Diagnostics Major Business
Table 31. Becton Dickinson STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Becton Dickinson SWOT Analysis
Table 33. Becton Dickinson STD Diagnostics Product and Solutions
Table 34. Becton Dickinson STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Technologies Corporate Information, Location and Competitors
Table 36. Agilent Technologies STD Diagnostics Major Business
Table 37. Agilent Technologies STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Agilent Technologies SWOT Analysis
Table 39. Agilent Technologies STD Diagnostics Product and Solutions
Table 40. Agilent Technologies STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Diadexus Corporate Information, Location and Competitors
Table 42. Diadexus STD Diagnostics Major Business
Table 43. Diadexus STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Diadexus SWOT Analysis
Table 45. Diadexus STD Diagnostics Product and Solutions
Table 46. Diadexus STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beckman Coulter/Danaher Corporate Information, Location and Competitors
Table 48. Beckman Coulter/Danaher STD Diagnostics Major Business
Table 49. Beckman Coulter/Danaher STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Beckman Coulter/Danaher SWOT Analysis
Table 51. Beckman Coulter/Danaher STD Diagnostics Product and Solutions
Table 52. Beckman Coulter/Danaher STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Axis-Shield Corporate Information, Location and Competitors
Table 54. Axis-Shield STD Diagnostics Major Business
Table 55. Axis-Shield STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Axis-Shield SWOT Analysis
Table 57. Axis-Shield STD Diagnostics Product and Solutions
Table 58. Axis-Shield STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Decode Genetics Corporate Information, Location and Competitors
Table 60. Decode Genetics STD Diagnostics Major Business
Table 61. Decode Genetics STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Decode Genetics SWOT Analysis
Table 63. Decode Genetics STD Diagnostics Product and Solutions
Table 64. Decode Genetics STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Qiagen Corporate Information, Location and Competitors
Table 66. Qiagen STD Diagnostics Major Business
Table 67. Qiagen STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. Qiagen SWOT Analysis
Table 69. Qiagen STD Diagnostics Product and Solutions
Table 70. Qiagen STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sequenom Corporate Information, Location and Competitors
Table 72. Sequenom STD Diagnostics Major Business
Table 73. Sequenom STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Sequenom SWOT Analysis
Table 75. Sequenom STD Diagnostics Product and Solutions
Table 76. Sequenom STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Diagnocure Corporate Information, Location and Competitors
Table 78. Diagnocure STD Diagnostics Major Business
Table 79. Diagnocure STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. Diagnocure SWOT Analysis
Table 81. Diagnocure STD Diagnostics Product and Solutions
Table 82. Diagnocure STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Sienco Corporate Information, Location and Competitors
Table 84. Sienco STD Diagnostics Major Business
Table 85. Sienco STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 86. Sienco SWOT Analysis
Table 87. Sienco STD Diagnostics Product and Solutions
Table 88. Sienco STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Roche Corporate Information, Location and Competitors
Table 90. Roche STD Diagnostics Major Business
Table 91. Roche STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 92. Roche SWOT Analysis
Table 93. Roche STD Diagnostics Product and Solutions
Table 94. Roche STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Polymedco Corporate Information, Location and Competitors
Table 96. Polymedco STD Diagnostics Major Business
Table 97. Polymedco STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 98. Polymedco SWOT Analysis
Table 99. Polymedco STD Diagnostics Product and Solutions
Table 100. Polymedco STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Diagnostica Stago/Trinity Biotech Corporate Information, Location and Competitors
Table 102. Diagnostica Stago/Trinity Biotech STD Diagnostics Major Business
Table 103. Diagnostica Stago/Trinity Biotech STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 104. Diagnostica Stago/Trinity Biotech SWOT Analysis
Table 105. Diagnostica Stago/Trinity Biotech STD Diagnostics Product and Solutions
Table 106. Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Siemens STD Diagnostics Type and Application
Table 108. Siemens STD Diagnostics Major Business
Table 109. Siemens STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 110. Siemens SWOT Analysis
Table 111. Siemens STD Diagnostics Product and Solutions
Table 112. Siemens STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. SDIX Corporate Information, Location and Competitors
Table 114. SDIX STD Diagnostics Major Business
Table 115. SDIX STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 116. SDIX SWOT Analysis
Table 117. SDIX STD Diagnostics Product and Solutions
Table 118. SDIX STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Diamedix Corporate Information, Location and Competitors
Table 120. Diamedix STD Diagnostics Major Business
Table 121. Diamedix STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 122. Diamedix SWOT Analysis
Table 123. Diamedix STD Diagnostics Product and Solutions
Table 124. Diamedix STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Sysmex Corporate Information, Location and Competitors
Table 126. Sysmex STD Diagnostics Major Business
Table 127. Sysmex STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 128. Sysmex SWOT Analysis
Table 129. Sysmex STD Diagnostics Product and Solutions
Table 130. Sysmex STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Zycare/Alere Corporate Information, Location and Competitors
Table 132. Zycare/Alere STD Diagnostics Major Business
Table 133. Zycare/Alere STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 134. Zycare/Alere SWOT Analysis
Table 135. Zycare/Alere STD Diagnostics Product and Solutions
Table 136. Zycare/Alere STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Wako Corporate Information, Location and Competitors
Table 138. Wako STD Diagnostics Major Business
Table 139. Wako STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 140. Wako SWOT Analysis
Table 141. Wako STD Diagnostics Product and Solutions
Table 142. Wako STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Tosoh Corporate Information, Location and Competitors
Table 144. Tosoh STD Diagnostics Major Business
Table 145. Tosoh STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 146. Tosoh SWOT Analysis
Table 147. Tosoh STD Diagnostics Product and Solutions
Table 148. Tosoh STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Takara Bio Corporate Information, Location and Competitors
Table 150. Takara Bio STD Diagnostics Major Business
Table 151. Takara Bio STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 152. Takara Bio SWOT Analysis
Table 153. Takara Bio STD Diagnostics Product and Solutions
Table 154. Takara Bio STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 155. ThermoFisher Corporate Information, Location and Competitors
Table 156. ThermoFisher STD Diagnostics Major Business
Table 157. ThermoFisher STD Diagnostics Total Revenue (USD Million) (2017-2018)
Table 158. ThermoFisher SWOT Analysis
Table 159. ThermoFisher STD Diagnostics Product and Solutions
Table 160. ThermoFisher STD Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 161. Global STD Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 162. Global STD Diagnostics Revenue Share by Players (2015-2020)
Table 163. Global STD Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 164. Global STD Diagnostics Revenue Market Share by Regions (2015-2020)
Table 165. North America STD Diagnostics Revenue by Countries (2015-2020)
Table 166. North America STD Diagnostics Revenue Market Share by Countries (2015-2020)
Table 167. Europe STD Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 168. Asia-Pacific STD Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 169. South America STD Diagnostics Revenue by Countries (2015-2020)
Table 170. South America STD Diagnostics Revenue Market Share by Countries (2015-2020)
Table 171. Middle East and Africa STD Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 172. Middle East and Africa STD Diagnostics Revenue Market Share by Countries (2015-2020)
Table 173. Global STD Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 174. Global STD Diagnostics Revenue Share by Type (2015-2020)
Table 175. Global STD Diagnostics Revenue Forecast by Type (2021-2025)
Table 176. Global STD Diagnostics Revenue by Application (2015-2020)
Table 177. Global STD Diagnostics Revenue Share by Application (2015-2020)
Table 178. Global STD Diagnostics Revenue Forecast by Application (2021-2025)
Table 179. Global STD Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. STD Diagnostics Picture
Figure 2. Global STD Diagnostics Revenue Market Share by Type in 2019
Figure 3. Chlamydia Testing Picture
Figure 4. Syphilis Testing Picture
Figure 5. Gonorrhea Testing Picture
Figure 6. Herpes Simplex Virus Testing Picture
Figure 7. Human Papilloma Virus Testing Picture
Figure 8. Human Immunodeficiency Virus Testing Picture
Figure 9. Chancroid Testing Picture
Figure 10. STD Diagnostics Revenue Market Share by Application in 2019
Figure 11. Laboratory Testing Picture
Figure 12. Point of Care Testing Picture
Figure 13. Global STD Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global STD Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global STD Diagnostics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players STD Diagnostics Revenue Market Share in 2019
Figure 22. Global Top 10 Players STD Diagnostics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global STD Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global STD Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 26. Global STD Diagnostics Revenue Market Share by Regions in 2018
Figure 27. North America STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Europe STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. South America STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. North America STD Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 33. North America STD Diagnostics Revenue Market Share by Countries in 2019
Figure 34. USA STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Canada STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. Europe STD Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe STD Diagnostics Revenue Market Share by Countries in 2019
Figure 39. Germany STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. UK STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. France STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Russia STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Italy STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific STD Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific STD Diagnostics Revenue Market Share by Countries in 2019
Figure 46. China STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Japan STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Korea STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. India STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. South America STD Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 52. South America STD Diagnostics Revenue Market Share by Countries in 2019
Figure 53. Brazil STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa STD Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa STD Diagnostics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. UAE STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa STD Diagnostics Revenue and Growth Rate (2015-2020)
Figure 61. Global STD Diagnostics Revenue Share by Type (2015-2020)
Figure 62. Global STD Diagnostics Revenue Share by Type in 2019
Figure 63. Global STD Diagnostics Market Share Forecast by Type (2021-2025)
Figure 64. Global Chlamydia Testing Revenue Growth Rate (2015-2020)
Figure 65. Global Syphilis Testing Revenue Growth Rate (2015-2020)
Figure 66. Global Gonorrhea Testing Revenue Growth Rate (2015-2020)
Figure 67. Global Herpes Simplex Virus Testing Revenue Growth Rate (2015-2020)
Figure 68. Global Human Papilloma Virus Testing Revenue Growth Rate (2015-2020)
Figure 69. Global Human Immunodeficiency Virus Testing Revenue Growth Rate (2015-2020)
Figure 70. Global Chancroid Testing Revenue Growth Rate (2015-2020)
Figure 71. Global STD Diagnostics Revenue Share by Application (2015-2020)
Figure 72. Global STD Diagnostics Revenue Share by Application in 2019
Figure 73. Global STD Diagnostics Market Share Forecast by Application (2021-2025)
Figure 74. Global Laboratory Testing Revenue Growth Rate (2015-2020)
Figure 75. Global Point of Care Testing Revenue Growth Rate (2015-2020)
Figure 76. Global STD Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global STD Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global STD Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America STD Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Europe STD Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific STD Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. South America STD Diagnostics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa STD Diagnostics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Abbott
Bio/Data
Alere/Biosite/Inverness
ADI/American Diagnostica
Becton Dickinson
Agilent Technologies
Diadexus
Beckman Coulter/Danaher
Axis-Shield
Decode Genetics
Qiagen
Sequenom
Diagnocure
Sienco
Roche
Polymedco
Diagnostica Stago/Trinity Biotech
Siemens
SDIX
Diamedix
Sysmex
Zycare/Alere
Wako
Tosoh
Takara Bio
ThermoFisher
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets